Table of Contents
Prolongation of the QT interval on an electrocardiogram (ECG) is a significant clinical concern because it can lead to a dangerous arrhythmia known as Torsades de Pointes (TdP). Certain medications are known to cause QT prolongation, increasing the risk of developing TdP, which can be life-threatening if not recognized and managed promptly.
Understanding the QT Interval
The QT interval measures the time from the start of the Q wave to the end of the T wave on an ECG. It reflects the total time for ventricular depolarization and repolarization. A prolonged QT interval indicates delayed repolarization, which predisposes to abnormal electrical activity in the heart.
Causes of QT Prolongation
- Medications, especially certain antiarrhythmics, antibiotics, antipsychotics, and antidepressants
- Electrolyte imbalances, such as hypokalemia, hypomagnesemia, and hypocalcemia
- Genetic conditions, including congenital long QT syndrome
- Other factors like bradycardia and heart failure
Medications Commonly Associated with QT Prolongation
- Antiarrhythmic drugs: amiodarone, sotalol, quinidine
- Antibiotics: macrolides (e.g., erythromycin), fluoroquinolones
- Antipsychotics: haloperidol, ziprasidone
- Antidepressants: tricyclics, certain SSRIs
Pathophysiology of Torsades de Pointes
Torsades de Pointes is a polymorphic ventricular tachycardia characterized by a twisting of the QRS complexes around the isoelectric line. It often occurs in the setting of a prolonged QT interval, which creates a substrate for early afterdepolarizations that trigger abnormal ventricular activity.
Clinical Features and Risks
Patients with drug-induced TdP may experience palpitations, dizziness, syncope, or sudden cardiac death. The risk increases with the degree of QT prolongation, the presence of additional risk factors, and the use of multiple QT-prolonging drugs.
Prevention and Management
Preventive measures include regular ECG monitoring, correcting electrolyte imbalances, and avoiding the combination of multiple QT-prolonging drugs. If TdP occurs, immediate treatment involves magnesium sulfate administration, cessation of offending drugs, and, if necessary, electrical cardioversion.
Key Takeaways
- QT prolongation can be caused by various medications and conditions.
- Drug-induced QT prolongation increases the risk of Torsades de Pointes.
- Monitoring ECG and electrolytes is essential in at-risk patients.
- Prompt recognition and treatment are vital to prevent serious outcomes.